LYMPHOKINE ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY

被引：0
|
作者：
EGGERMONT, AMM [1 ]
SUGARBAKER, PH [1 ]
机构：
[1] NCI,BETHESDA,MD 20892
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1987年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [1] LYMPHOKINE-ACTIVATED KILLER-CELL AND INTERLEUKIN-2 INHIBITORS - THEIR ROLE IN ADOPTIVE IMMUNOTHERAPY
    EGGERMONT, AMM
    SUGARBAKER, PH
    CELLULAR IMMUNOLOGY, 1987, 107 (02) : 384 - 394
  • [2] THE ROLE OF EOSINOPHILS IN INTERLEUKIN-2/LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY
    ISHIMITSU, T
    TORISU, M
    SURGERY, 1993, 113 (02) : 192 - 199
  • [3] CHARACTERIZATION AND MODULATION OF HUMAN LYMPHOKINE (INTERLEUKIN-2) ACTIVATED KILLER-CELL INDUCTION
    HOYER, M
    MEINEKE, T
    LEWIS, W
    ZWILLING, B
    RINEHART, J
    CANCER RESEARCH, 1986, 46 (06) : 2834 - 2838
  • [4] THE ADOPTIVE IMMUNOTHERAPY OF CANCER USING LYMPHOKINE ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2
    ETTINGHAUSEN, SE
    ROSENBERG, SA
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (01): : 51 - 71
  • [5] AUGMENTATION OF INSULIN AUTOANTIBODIES FOLLOWING INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER-CELL THERAPY
    BERGSTROM, RW
    ATKINS, MB
    MIER, JW
    PALMER, JP
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1990, 31 (04) : 189 - 193
  • [6] IMMUNOTHERAPY OF TUMORS WITH INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER CELLS
    JOST, LM
    GMUR, J
    OELZ, O
    SAUTER, C
    STAHEL, RA
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 119 (05) : 137 - 143
  • [7] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY - ANALYSIS OF A BOLUS INTERLEUKIN-2 AND A CONTINUOUS INFUSION INTERLEUKIN-2 REGIMEN
    CLARK, JW
    SMITH, JW
    STEIS, RG
    URBA, WJ
    CRUM, E
    MILLER, R
    MCKNIGHT, J
    BEMAN, JA
    STEVENSON, HC
    CREEKMORE, S
    STEWART, M
    CONLON, K
    SZNOL, M
    KREMERS, P
    COHEN, P
    LONGO, DL
    CANCER RESEARCH, 1990, 50 (22) : 7343 - 7350
  • [8] REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES
    KEILHOLZ, U
    SCHEIBENBOGEN, C
    BRADO, M
    GEORGI, P
    MACLACHLAN, D
    BRADO, B
    HUNSTEIN, W
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) : 103 - 105
  • [9] ADOPTIVE IMMUNOTHERAPY OF A RAT GLIOMA USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2
    TZENG, JJ
    BARTH, RF
    CLENDENON, NR
    GORDON, WA
    CANCER RESEARCH, 1990, 50 (14) : 4338 - 4343
  • [10] LABORATORY CORRELATES OF ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN HUMANS
    BOLDT, DH
    MILLS, BJ
    GEMLO, BT
    HOLDEN, H
    MIER, J
    PAIETTA, E
    MCMANNIS, JD
    ESCOBEDO, LV
    SNIECINSKI, I
    RAYNER, AA
    HAWKINS, MJ
    ATKINS, MB
    CIOBANU, N
    ELLIS, TM
    CANCER RESEARCH, 1988, 48 (15) : 4409 - 4416
12345